{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T20:19:02Z","timestamp":1771273142333,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Genetic Engineering and Biotechnology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jgeb.2025.100544","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T06:15:36Z","timestamp":1754374536000},"page":"100544","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Licoisoflavone B and glabridin from Glycyrrhiza glabra as potent nucleoprotein antagonists of Lassa virus: insights from molecular docking, dynamics simulation, PCA, and DFT studies"],"prefix":"10.1016","volume":"23","author":[{"given":"Sk.","family":"Faisal Ahmed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md.","family":"Masudur Rahman Munna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md.","family":"Hossain Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md.","family":"Mostafizur Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minhajul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esha Mony","family":"Bristy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jgeb.2025.100544_b0005","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/10408360490497456","article-title":"Lassa virus","volume":"41","author":"G\u00fcnther","year":"2004","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/j.jgeb.2025.100544_b0010","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.2147\/DDDT.S147276","article-title":"Current research for a vaccine against Lassa hemorrhagic fever virus","volume":"12","author":"Warner","year":"2018","journal-title":"Drug Des Devel Ther"},{"issue":"30","key":"10.1016\/j.jgeb.2025.100544_b0015","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2201208119","article-title":"Proximity interactome analysis of Lassa polymerase reveals eRF3a\/GSPT1 as a druggable target for host-directed antivirals","volume":"119","author":"Fang","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jgeb.2025.100544_b0020","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1206872","article-title":"Development of a new drug candidate for the inhibition of Lassa virus glycoprotein and nucleoprotein by modification of evodiamine as promising therapeutic agents","volume":"14","author":"Akash","year":"2023","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jgeb.2025.100544_b0025","doi-asserted-by":"crossref","unstructured":"Huang C, Mantlo E, Paessler S. \u201cLassa virus NP DEDDh 3\u2032-5\u2032 exoribonuclease activity is required for optimal viral RNA replication and mutation control.\u201d bioRxiv, Apr. 2023. doi: 10.1101\/2023.04.12.536665.","DOI":"10.1101\/2023.04.12.536665"},{"issue":"12","key":"10.1016\/j.jgeb.2025.100544_b0030","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.3201\/eid1212.060812","article-title":"Mastomys natalensi s and Lassa fever, West Africa","volume":"12","author":"Lecompte","year":"2006","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"10.1016\/j.jgeb.2025.100544_b0035","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1073\/pnas.1016404108","article-title":"Structure of the Lassa virus nucleoprotein reveals a dsRNA-specific 3\u2032 to 5\u2032 exonuclease activity essential for immune suppression","volume":"108","author":"Hastie","year":"2011","journal-title":"Proc Natl Acad Sci"},{"issue":"46","key":"10.1016\/j.jgeb.2025.100544_b0040","doi-asserted-by":"crossref","first-page":"20069","DOI":"10.1073\/pnas.1007152107","article-title":"Assembly of a functional Machupo virus polymerase complex","volume":"107","author":"Kranzusch","year":"2010","journal-title":"Proc Natl Acad Sci"},{"issue":"7","key":"10.1016\/j.jgeb.2025.100544_b0045","doi-asserted-by":"crossref","first-page":"4519","DOI":"10.1128\/JVI.79.7.4519-4526.2005","article-title":"Dual role of the lymphocytic choriomeningitis virus intergenic region in transcription termination and virus propagation","volume":"79","author":"Pinschewer","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.jgeb.2025.100544_b0050","doi-asserted-by":"crossref","unstructured":"Levingston Macleod JM, D\u2019Antuono A, Loureiro ME, Casabona JC, Gomez GA, Lopez N. Identification of two functional domains within the arenavirus nucleoprotein. J Virol, 85(5), pp. 2012\u20132023, Mar. 2011, doi: 10.1128\/JVI.01875-10.","DOI":"10.1128\/JVI.01875-10"},{"key":"10.1016\/j.jgeb.2025.100544_b0055","doi-asserted-by":"crossref","unstructured":"S\u00e4nger L, et al. An RNA to rule them all: Critical steps in Lassa virus ribonucleoparticle assembly and recruitment. Feb. 2023. doi: 10.1101\/2023.02.09.527830.","DOI":"10.1101\/2023.02.09.527830"},{"issue":"3","key":"10.1016\/j.jgeb.2025.100544_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.jgeb.2024.100406","article-title":"Unveiling promising phytocompounds from Moringa oleifera as dual inhibitors of EGFR(T790M\/C797S) and VEGFR-2 in non-small cell lung cancer through in silico screening, ADMET, dynamics simulation, and DFT analysis","volume":"22","author":"Masudur Rahman Munna","year":"2024","journal-title":"J Genet Eng Biotechnol"},{"issue":"1","key":"10.1016\/j.jgeb.2025.100544_b0065","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The protein data bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jgeb.2025.100544_b0070","unstructured":"\u201cBIOVIA, Dassault Syst\u00e8mes, Discovery Studio Visualizer, Release 2024; BIOVIA Pipeline Pilot, Release 2024, San Diego: Dassault Syst\u00e8mes, 2024.\u201d."},{"key":"10.1016\/j.jgeb.2025.100544_b0075","doi-asserted-by":"crossref","unstructured":"Guex N, Peitsch MC, Schwede T. Automated comparative protein structure modeling with SWISS\u2010MODEL and Swiss\u2010PdbViewer: A historical perspective. Electrophoresis, 30(S1), Jun. 2009, doi: 10.1002\/elps.200900140.","DOI":"10.1002\/elps.200900140"},{"issue":"9","key":"10.1016\/j.jgeb.2025.100544_b0080","doi-asserted-by":"crossref","first-page":"8827","DOI":"10.1021\/acsomega.3c00156","article-title":"IMPPAT 2.0: an enhanced and expanded phytochemical atlas of indian medicinal plants","volume":"8","author":"Vivek-Ananth","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.jgeb.2025.100544_b0085","doi-asserted-by":"crossref","unstructured":"Kim S, et al. PubChem 2025 update. Nucleic Acids Res, 53, 2024, 1516\u20131525, 2025.","DOI":"10.1093\/nar\/gkae1059"},{"issue":"10","key":"10.1016\/j.jgeb.2025.100544_b0090","first-page":"1","article-title":"Open babel: an open chemical toolbox","volume":"3","author":"O\u2019Boyle","year":"2011","journal-title":"J Cheminform"},{"key":"10.1016\/j.jgeb.2025.100544_b0095","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-1-4939-2269-7_19","article-title":"Small-molecule library screening by docking with PyRx","volume":"1263","author":"Dallakyan","year":"2015","journal-title":"Methods Mol Biol"},{"issue":"3","key":"10.1016\/j.jgeb.2025.100544_b0100","doi-asserted-by":"crossref","first-page":"55","DOI":"10.22271\/phyto.2020.v9.i3a.11480","article-title":"Inhibition of multidrug resistance property of Candida albicans by natural compounds of parthenium hysterophorus L. an in-silico approach","volume":"9","author":"Verma","year":"2020","journal-title":"J Pharmacogn Phytochem"},{"key":"10.1016\/j.jgeb.2025.100544_b0105","doi-asserted-by":"crossref","unstructured":"Munna MMR, Tusar MTT, Shanta SS, Ahmed MH, Ali MS. Identification of dual inhibitors for EGFR(T790M\/C797S) and VEGFR-2 in non-small cell lung cancer from Moringa oleifera derived phytochemicals: an in-silico approach. Apr. 2024. doi: 10.21203\/rs.3.rs-4284215\/v1.","DOI":"10.21203\/rs.3.rs-4284215\/v1"},{"issue":"March","key":"10.1016\/j.jgeb.2025.100544_b0110","first-page":"1","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jgeb.2025.100544_b0115","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.addr.2012.09.019","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"64(SUPPL)","author":"Lipinski","year":"2012","journal-title":"Adv Drug Deliv Rev"},{"issue":"21","key":"10.1016\/j.jgeb.2025.100544_b0120","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1021\/jm000292e","article-title":"Prediction of drug absorption using multivariate statistics","volume":"43","author":"Egan","year":"2000","journal-title":"J Med Chem"},{"issue":"12","key":"10.1016\/j.jgeb.2025.100544_b0125","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J Med Chem"},{"issue":"9","key":"10.1016\/j.jgeb.2025.100544_b0130","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures","volume":"58","author":"Pires","year":"2015","journal-title":"J Med Chem"},{"issue":"W1","key":"10.1016\/j.jgeb.2025.100544_b0135","doi-asserted-by":"crossref","first-page":"W257","DOI":"10.1093\/nar\/gky318","article-title":"ProTox-II: a webserver for the prediction of toxicity of chemicals","volume":"46","author":"Banerjee","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jgeb.2025.100544_b0140","unstructured":"L. The PyMOL Molecular Graphics System, Version 3.0 Schr\u00f6dinger, \u201cNo Title.\u201d."},{"issue":"9","key":"10.1016\/j.jgeb.2025.100544_b0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0258061","article-title":"Molecular dynamics and protein frustration analysis of human fused in sarcoma protein variants in amyotrophic lateral sclerosis type 6: an in silico approach","volume":"16","author":"Bonet","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.jgeb.2025.100544_b0150","first-page":"405","author":"Krieger","year":"2012","journal-title":"Assignment of Protonation States in Proteins and Ligands: Combining pKa Prediction with Hydrogen Bonding Network Optimization"},{"issue":"8","key":"10.1016\/j.jgeb.2025.100544_b0155","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1021\/acs.jctc.5b00255","article-title":"ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB","volume":"11","author":"Maier","year":"2015","journal-title":"J Chem Theory Comput"},{"issue":"16","key":"10.1016\/j.jgeb.2025.100544_b0160","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/jcc.10128","article-title":"Fast, efficient generation of high\u2010quality atomic charges. AM1\u2010BCC model: II. Parameterization and validation","volume":"23","author":"Jakalian","year":"2002","journal-title":"J Comput Chem"},{"issue":"9","key":"10.1016\/j.jgeb.2025.100544_b0165","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general amber force field","volume":"25","author":"Wang","year":"2004","journal-title":"J Comput Chem"},{"issue":"4","key":"10.1016\/j.jgeb.2025.100544_b0170","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.jmgm.2006.02.009","article-title":"Fast empirical pKa prediction by Ewald summation","volume":"25","author":"Krieger","year":"2006","journal-title":"J Mol Graph Model"},{"key":"10.1016\/j.jgeb.2025.100544_b0175","doi-asserted-by":"crossref","unstructured":"Islam R, et al. A molecular modeling approach to identify effective antiviral phytochemicals against the main protease of SARS-CoV-2. J Biomol Struct Dyn, pp. 1\u201312, May 2020, doi: 10.1080\/07391102.2020.1761883.","DOI":"10.1080\/07391102.2020.1761883"},{"issue":"11","key":"10.1016\/j.jgeb.2025.100544_b0180","first-page":"Nov","article-title":"\u2018Drug-likeness\u2019 properties of natural compounds","volume":"4","author":"Ntie-Kang","year":"2019","journal-title":"Phys Sci Rev"},{"issue":"12","key":"10.1016\/j.jgeb.2025.100544_b0185","first-page":"Dec","article-title":"Fundamental physical and chemical concepts behind \u2018drug-likeness\u2019 and \u2018natural product-likeness,","volume":"4","author":"Athar","year":"2019","journal-title":"Phys Sci Rev"},{"issue":"17","key":"10.1016\/j.jgeb.2025.100544_b0190","doi-asserted-by":"crossref","first-page":"6617","DOI":"10.1080\/07391102.2020.1796812","article-title":"Virtual screening, ADMET prediction and dynamics simulation of potential compounds targeting the main protease of SARS-CoV-2","volume":"39","author":"Yadav","year":"2021","journal-title":"J Biomol Struct Dyn"},{"issue":"9","key":"10.1016\/j.jgeb.2025.100544_b0195","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/cmdc.200600155","article-title":"Prediction of ADMET properties","volume":"1","author":"Norinder","year":"2006","journal-title":"ChemMedChem"},{"issue":"1","key":"10.1016\/j.jgeb.2025.100544_b0200","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12987-020-00230-3","article-title":"A blood\u2013brain barrier overview on structure, function, impairment, and biomarkers of integrity","volume":"17","author":"Kadry","year":"2020","journal-title":"Fluids Barriers CNS"},{"issue":"2","key":"10.1016\/j.jgeb.2025.100544_b0205","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3390\/molecules27020515","article-title":"Enzyme activity of Natural Products on Cytochrome P450","volume":"27","author":"Zuo","year":"2022","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.jgeb.2025.100544_b0210","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1743-7075-5-27","article-title":"Role of cytochrome P450 in drug interactions","volume":"5","author":"Bibi","year":"2008","journal-title":"Nutr Metab (Lond)"},{"issue":"12","key":"10.1016\/j.jgeb.2025.100544_b0215","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/nrd.2016.184","article-title":"Phase II and phase III failures: 2013\u20132015","volume":"15","author":"Harrison","year":"2016","journal-title":"Nat Rev Drug Discov"},{"issue":"7","key":"10.1016\/j.jgeb.2025.100544_b0220","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/d41573-019-00074-z","article-title":"Trends in clinical success rates and therapeutic focus","volume":"18","author":"Dowden","year":"2019","journal-title":"Nat Rev Drug Discov"},{"issue":"12","key":"10.1016\/j.jgeb.2025.100544_b0225","doi-asserted-by":"crossref","first-page":"8793","DOI":"10.1016\/j.arabjc.2020.10.009","article-title":"Linked drug-drug conjugates based on triterpene and phenol structures. Rational synthesis, molecular properties, toxicity and bioactivity prediction","volume":"13","author":"Pawe\u0142czyk","year":"2020","journal-title":"Arab J Chem"},{"issue":"1","key":"10.1016\/j.jgeb.2025.100544_b0230","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3390\/v15010146","article-title":"Combating lassa fever in west african sub-region: progress, challenges, and future perspectives","volume":"15","author":"Aloke","year":"2023","journal-title":"Viruses"},{"issue":"February","key":"10.1016\/j.jgeb.2025.100544_b0235","first-page":"1","article-title":"Glabridin prevents doxorubicin-induced cardiotoxicity through gut microbiota modulation and colonic macrophage polarization in mice","volume":"10","author":"Huang","year":"2019","journal-title":"Front Pharmacol"}],"container-title":["Journal of Genetic Engineering and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687157X25000885?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687157X25000885?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T07:10:33Z","timestamp":1755933033000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1687157X25000885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1687157X25000885"],"URL":"https:\/\/doi.org\/10.1016\/j.jgeb.2025.100544","relation":{},"ISSN":["1687-157X"],"issn-type":[{"value":"1687-157X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Licoisoflavone B and glabridin from Glycyrrhiza glabra as potent nucleoprotein antagonists of Lassa virus: insights from molecular docking, dynamics simulation, PCA, and DFT studies","name":"articletitle","label":"Article Title"},{"value":"Journal of Genetic Engineering and Biotechnology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgeb.2025.100544","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of Academy of Scientific Research and Technology.","name":"copyright","label":"Copyright"}],"article-number":"100544"}}